| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5902200 | Journal of Diabetes and its Complications | 2014 | 7 Pages |
Abstract
Progression of CKD in T2D drives substantial medical care costs. Interventions designed to minimize decline in progressive kidney function, particularly among patients with stage 3 or 4 CKD, may reduce the economic burden of CKD in T2D.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Suma Vupputuri, Teresa M. Kimes, Michael O. Calloway, Jennifer B. Christian, David Bruhn, Alan A. Martin, Gregory A. Nichols,